Nucleation of α-Synuclein Amyloid Fibrils Induced by Cross-Interaction with β-Hairpin Peptides Derived from Immunoglobulin Light Chains.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
09 Nov 2023
Historique:
received: 15 09 2023
revised: 30 10 2023
accepted: 07 11 2023
medline: 27 11 2023
pubmed: 25 11 2023
entrez: 25 11 2023
Statut: epublish

Résumé

Heterologous interactions between different amyloid-forming proteins, also called cross-interactions, may have a critical impact on disease-related amyloid formation. β-hairpin conformers of amyloid-forming proteins have been shown to affect homologous interactions in the amyloid self-assembly process. Here, we applied two β-hairpin-forming peptides derived from immunoglobulin light chains as models to test how heterologous β-hairpins modulate the fibril formation of Parkinson's disease-associated protein α-synuclein (αSyn). The peptides SMAhp and LENhp comprise β-strands C and C' of the κ4 antibodies SMA and LEN, which are associated with light chain amyloidosis and multiple myeloma, respectively. SMAhp and LENhp bind with high affinity to the β-hairpin-binding protein β-wrapin AS10 according to isothermal titration calorimetry and NMR spectroscopy. The addition of SMAhp and LENhp affects the kinetics of αSyn aggregation monitored by Thioflavin T (ThT) fluorescence, with the effect depending on assay conditions, salt concentration, and the applied β-hairpin peptide. In the absence of agitation, substoichiometric concentrations of the hairpin peptides strongly reduce the lag time of αSyn aggregation, suggesting that they support the nucleation of αSyn amyloid fibrils. The effect is also observed for the aggregation of αSyn fragments lacking the N-terminus or the C-terminus, indicating that the promotion of nucleation involves the interaction of hairpin peptides with the hydrophobic non-amyloid-β component (NAC) region.

Identifiants

pubmed: 38003322
pii: ijms242216132
doi: 10.3390/ijms242216132
pmc: PMC10671648
pii:
doi:

Substances chimiques

alpha-Synuclein 0
Amyloid 0
Immunoglobulin Light Chains 0
Amyloidogenic Proteins 0
Amyloid beta-Peptides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : European Research Council
ID : 726368
Pays : International

Références

Immunity. 2000 Oct;13(4):433-42
pubmed: 11070162
Neuron. 2020 Jan 22;105(2):260-275.e6
pubmed: 31759806
Comput Chem Eng. 2018 Aug 4;116:322-332
pubmed: 30405276
J Mol Biol. 2017 Oct 13;429(20):3018-3030
pubmed: 28918091
Angew Chem Int Ed Engl. 2014 Apr 14;53(16):4227-30
pubmed: 24623599
J Chem Phys. 2013 Oct 28;139(16):165103
pubmed: 24182084
Nat Chem Biol. 2015 Mar;11(3):229-34
pubmed: 25643172
Biophys Chem. 2021 Feb;269:106519
pubmed: 33333378
Anal Biochem. 2010 May 15;400(2):270-81
pubmed: 20149780
Nat Rev Neurosci. 2013 Jan;14(1):38-48
pubmed: 23254192
J Biol Chem. 2003 Jan 31;278(5):3235-40
pubmed: 12435752
J Am Chem Soc. 2023 Aug 23;145(33):18340-18354
pubmed: 37555670
Proteins. 2005 Jun 1;59(4):687-96
pubmed: 15815974
Biochemistry. 2009 Mar 10;48(9):1870-7
pubmed: 19216516
Elife. 2019 Aug 21;8:
pubmed: 31389332
Annu Rev Biochem. 2013;82:745-74
pubmed: 23451869
J Chem Phys. 2013 Apr 21;138(15):155101
pubmed: 23614446
Proc Natl Acad Sci U S A. 2021 Mar 9;118(10):
pubmed: 33649211
Mol Immunol. 1997 Dec;34(18):1291-301
pubmed: 9683271
Handb Clin Neurol. 2018;153:321-335
pubmed: 29887143
J Am Chem Soc. 2009 Dec 30;131(51):18283-92
pubmed: 19950949
Acta Neuropathol. 2018 Jun;135(6):877-886
pubmed: 29536165
J Am Chem Soc. 2018 Aug 1;140(30):9685-9695
pubmed: 29989407
J Mol Biol. 2011 Jul 8;410(2):357-67
pubmed: 21616081
PLoS One. 2014 Jan 31;9(1):e87354
pubmed: 24498083
J Biol Chem. 2002 Apr 12;277(15):12657-65
pubmed: 11815605
Neurochem Res. 2006 Sep;31(9):1153-62
pubmed: 16947080
J Am Chem Soc. 2014 Feb 19;136(7):2866-75
pubmed: 24460028
J Struct Biol. 2000 Jun;130(2-3):280-9
pubmed: 10940232
Proc Natl Acad Sci U S A. 2010 Aug 31;107(35):15595-600
pubmed: 20713699
Angew Chem Int Ed Engl. 2014 Nov 17;53(47):12756-60
pubmed: 25256598
Biochemistry. 2004 Apr 27;43(16):4655-61
pubmed: 15096033
Curr Top Med Chem. 2012;12(22):2523-33
pubmed: 23339305
J Am Chem Soc. 2010 Jan 20;132(2):532-9
pubmed: 20020713
J Biomol NMR. 1995 Nov;6(3):277-93
pubmed: 8520220
Biophys Rev. 2018 Apr;10(2):527-534
pubmed: 29214606
Chembiochem. 2015 Feb 9;16(3):411-4
pubmed: 25557164
Biophys J. 2010 Oct 6;99(7):2208-16
pubmed: 20923655
Amyloid. 2003 Jun;10(2):97-109
pubmed: 12964417
Biochemistry. 2005 Apr 26;44(16):6003-14
pubmed: 15835889
J Mol Biol. 2013 Sep 23;425(18):3338-59
pubmed: 23811057
Biophys J. 2013 Jun 18;104(12):2714-24
pubmed: 23790380
NPJ Parkinsons Dis. 2021 Jul 26;7(1):65
pubmed: 34312398
ACS Chem Neurosci. 2012 Mar 21;3(3):211-20
pubmed: 22860190
Int Rev Cell Mol Biol. 2017;329:187-226
pubmed: 28109328
J Phys Chem B. 2015 Aug 20;119(33):10478-87
pubmed: 26228450
ACS Nano. 2015 Sep 22;9(9):9070-7
pubmed: 26391443
Sci Rep. 2017 May 24;7(1):2344
pubmed: 28539626
Chem Commun (Camb). 2016 Jan 28;52(8):1733-6
pubmed: 26666686
Nat Rev Mol Cell Biol. 2018 Dec;19(12):755-773
pubmed: 30237470
J Phys Chem B. 2012 Jun 7;116(22):6311-25
pubmed: 22587454
Sci Rep. 2017 Sep 18;7(1):11811
pubmed: 28924167
Chem Sci. 2020 Sep 28;11(41):11331-11337
pubmed: 34094375
Proc Natl Acad Sci U S A. 2014 May 27;111(21):7671-6
pubmed: 24817693
Methods Mol Biol. 2014;1216:15-52
pubmed: 25213409
ACS Chem Neurosci. 2019 Nov 20;10(11):4757-4765
pubmed: 31642657
Protein Sci. 1995 Mar;4(3):421-32
pubmed: 7795526
Mol Cell. 2011 Jul 8;43(1):72-84
pubmed: 21726811
Protein Sci. 2005 Jun;14(6):1581-96
pubmed: 15930005
J Chem Phys. 2015 Dec 28;143(24):243142
pubmed: 26723627
Protein Sci. 1999 Mar;8(3):509-17
pubmed: 10091653
J Phys Chem B. 2009 Jan 29;113(4):1162-72
pubmed: 19125574
Bio Protoc. 2018 Jul 20;8(14):
pubmed: 30069495
Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):12473-12477
pubmed: 27791129
J Phys Chem B. 2016 Dec 22;120(50):12781-12794
pubmed: 27934063
Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):11835-11840
pubmed: 27698130

Auteurs

Laetitia F Heid (LF)

Institut für Physikalische Biologie, Heinrich Heine University Düsseldorf, 40204 Düsseldorf, Germany.

Tatsiana Kupreichyk (T)

Institut für Physikalische Biologie, Heinrich Heine University Düsseldorf, 40204 Düsseldorf, Germany.
Institute of Biological Information Processing (IBI-7) and JuStruct, Jülich Center for Structural Biology, Forschungszentrum Jülich, 52425 Jülich, Germany.

Marie P Schützmann (MP)

Institut für Physikalische Biologie, Heinrich Heine University Düsseldorf, 40204 Düsseldorf, Germany.

Walfried Schneider (W)

Institut für Physikalische Biologie, Heinrich Heine University Düsseldorf, 40204 Düsseldorf, Germany.

Matthias Stoldt (M)

Institute of Biological Information Processing (IBI-7) and JuStruct, Jülich Center for Structural Biology, Forschungszentrum Jülich, 52425 Jülich, Germany.

Wolfgang Hoyer (W)

Institut für Physikalische Biologie, Heinrich Heine University Düsseldorf, 40204 Düsseldorf, Germany.
Institute of Biological Information Processing (IBI-7) and JuStruct, Jülich Center for Structural Biology, Forschungszentrum Jülich, 52425 Jülich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH